Armata Pharmaceuticals Inc.

ARMP | AMEX

Price Alert Chart Builder DCF Calculator

$4.26

+$0.08 (+1.91%)

At close: Sep 21, 2026, 4:00 PM ET

$4.15

-$0.11 (-2.58%)

Pre-market: Sep 22, 2026, 5:22 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.91%

(1D)

Rating

Updated: Aug 25, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $156.39M

1D Range

4.18 4.35

52W Range

2.94 16.34

Valuation (TTM)

PE -0.56

PB -0.68

EV/EBITDA -1.42

Valuation (NTM)

Forward PE N/A

Forward PEG 0.04

Price Target $15

Cash Flow

FCF Yield -16.5%

SBC Adj. FCF Yield -20.1%

SBC Impact -22.2%

Margins

Gross Margin 68.2%

Operating Margin -1233.6%

FCF Margin -781.9%

Growth (CAGR)

Revenue 3Y | 5Y -7.5% | 1.7%

Dil EPS 3Y | 5Y -73.6% | -50.4%

FCF 3Y | 5Y 29.3% | 6.7%

Returns

ROA -213.7%

ROE 89.7%

ROIC -47.4%

Financial Health

Net Debt

$84.07M

Current Ratio 0.11

Interest Coverage -1.90

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections...

Sector Healthcare

Industry Biotechnology

Employees 61

IPO Date May 19, 1994

Website www.armatapharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$15

Upside

+252.11%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞